HD Regulatory Science Consortium (HD-RSC) A consortium aimed at accelerating treatments for Huntington’s disease Kick-Off Meeting, Sheraton Silver Spring Hotel, November 6-7, 2017
HDRegulatoryScienceConsortium(HD-RSC)AconsortiumaimedatacceleratingtreatmentsforHuntington’sdisease
Kick-OffMeeting,SheratonSilverSpringHotel,November6-7,2017
Robi BlumensteinCHDIFoundation
“TheVision:CHDI’sDedicationtoSuccessfulHDTreatments”
2
MarthaBrumfieldCriticalPathInstitute
“Consortia-BasedStrategiesinNeurodegenerativeDiseases:CriticalPath
Institute’sTrackRecordinCollaborativeEfforts”
3
MikePanzara,WaveLifeSciencesScottSchobel,RocheLouiseVetter,HDSA
JulianaBronzova,UniQureMarkGordon,Teva
“TheNeed:WhataretheKeyChallengesforDrugDevelopmentinHD”
4
Moderator:JeffCarroll,WesternWashingtonUniversity
BillyDunnFDA
“RegulatoryImpactforHuntington’sDisease:FDAPerspectives”
5
10:35AM– 10:50AMBREAK
6
ManuelHaasEMA
“RegulatoryImpactforHuntington’sDisease:EMAPerspectives”
7
Issam ZinehFDA
“ModelInformedDrugDevelopment”
8
BrianCorriganPfizer
“FromModel-BasedClinicalTrialEnrichmenttoComprehensiveClinicalTrialSimulation”
9
11:45AM– 12:30PM
LUNCH
10
AmritaMohanCHDIFoundation
“SuccessinSharingDatafromHDNaturalHistoryStudies”
11
BrianCorrigan,PfizerBernhardLandwehrmeyer,UlmUniversity
KevinKrudys,FDAGeraldPodskalny,FDA
CharlesVenuto,UniversityofRochester
“HDDiseaseProgressionModeling:AligningDatawithContextofUseApplications”
12
Moderator:KlausRomero,CriticalPathInstitute
1:30PM– 1:45PM
BREAK
13
CristinaSampaioCHDIFoundation
“RationaleandImpactofBuildingaComprehensiveHDClinicalDatabase”
14
EricSiemersEliLilly
“BiomarkersasToolstoEnableDecision-MakinginHDDrugDevelopment”
15
GlennStebbinsRushUniversity
“ClinicalOutcomeMeasuresinHD:BeyondUHDRS”
16
SteveHersch,VoyagerBernardRavina,Voyager
BillyDunn,FDAEricBastings,FDA
“OutliningaRoadmapforClinicalTrialsinPre-ManifestHD”
17
Moderator:KarlKieburtz,UniversityofRochester
3:45PM– 4:00PMBREAK
18
CharlesSabinePatientAdvocate
“TheImpact:WhyThisMatterstoPatients”
19
6:00PMDINNERat:
CopperCanyonGrill928EllsworthDriveSilverSpring,MD
20
EmilyGantmanCHDIFoundation
“SummaryandHighlightsfromDay1ObjectivesforDay2”
21
DianeStephenson&DebraHannaCriticalPathInstitute
“TheOperations:HowHD-RSCWillWork”
22
Q&A23
DianeStephensonCriticalPathInstitute
IntroductiontoBreakoutSessions
24
10:00AM– 10:15AM
BREAK
25
10:15AM– 12:00PMBREAKOUTSESSIONS
1)Model-basedStrategiesforClinicalTrailEnrichment:FocusonBiomarkersRoom:Magnolia
2)ClinicalOutcomeAssessmentMeasuresinHDforUseinTrialsRoom:Persimmon1
3)TherapeuticDevelopmentinPre-manifestHD:OpportunitiesandChallengesRoom:Persimmon2
26
CristinaSampaioCHDIFoundation
“MeetingSummaryandConclusions”
27